#cgm

2 stories

#benuvia operations #business #cash flow #continuous glucose monitoring #deactivated #diabetes technology #earnings #ibogaine #insulin pumps #margin pressure #medical devices #medtronic

Psyence BioMed Partners with Benuvia for U.S. Ibogaine Manufacturing
Psyence BioMed and Benuvia launch U.S. pharmaceutical-grade ibogaine production under DEA-registered facility.
Financialpost · 1m
MiniMed's growth story hides a cash flow problem
Nine analysts raised targets, but the diabetes tech company faces margin pressure and Medtronic separation risks.
Alphastreet - Earnings Decoded. Market Intelligence Delivered · 1m